Dafna Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 242,000 shares of ORIC stock, worth $2.21 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
242,000Holding current value
$2.21 Million% of portfolio
0.41%Shares
7 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$60 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$48.3 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$48.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$44.1 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$36.6 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $361M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...